title: Primary hyperoxaluria in an adult presenting with end-stage renal failure together with hypercalcemia and hypothyroidism.
abstract: Primary hyperoxaluria (PH) is a rare genetic disorder characterized by overproduction of oxalate due to specific enzyme deficiencies in glyoxylate metabolism. The primary clinical presentation is in the form of recurrent urolithiasis, progressive nephrocalcinosis, end-stage renal disease, and systemic oxalosis. Herein, we present a case of PH who was diagnosed at 47 years of age after 6 years on hemodialysis. He presented with fatigue, anorexia, weight loss, and was found to have cachexia, diffuse edema, hepatomegaly, ascites, hypercalcemia, hyperphosphatemia, hypoalbuminemia, low parathyroid hormone levels, lytic and resorptive areas in the vertebrae, diffusely increased echogenity of the liver, multiple renal stones, and bilateral nephrocalcinosis. Bone marrow biopsy showed calcium oxalate crystals and crystal granulomas. The liver biopsy could not be performed. The absence of an identifiable reason for secondary forms, the severity of the clinical presentation, and pathological findings led to the diagnosis of PH2. He died while waiting for a potential liver and kidney donor. The presented case is consistent with the literature as he had renal stone disease in the third decade and end-stage renal disease in the fifth decade. Hypercalcemia was thought to be due to osteoclast-stimulating activity of macrophages constituting the granuloma. Erythropoietin-resistant anemia and hypothyroidism were thought to be due to accumulation of oxalate in the bone marrow and thyroid gland, respectively. It is very important to keep in mind the possibility of PH when faced with a patient with nephrocalcinosis and oxalate stone disease.
authors: Department of Nephrology, Haseki Training and Research Hospital, Istanbul, Turkey.
authors: Serhat
authors: S
authors: Karadag
authors: Meltem
authors: M
authors: Gursu
authors: Zeki
authors: Z
authors: Aydin
authors: Sami
authors: S
authors: Uzun
authors: Oner
authors: O
authors: Dogan
authors: Savas
authors: S
authors: Ozturk
authors: Rumeyza
authors: R
authors: Kazancioglu
mesh_terms: D001201:Ascites / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D006099:Granuloma / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006529:Hepatomegaly / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D006960:Hyperoxaluria, Primary / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D007037:Hypothyroidism / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D010070:Oxalates / Q000378:metabolism; D006435:Renal Dialysis; D052878:Urolithiasis / Q000097:blood / Q000150:complications / Q000473:pathology / Q000628:therapy
chemical_list: D010070:Oxalates